The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 15, Pages 2331-2341
Publisher
Informa Healthcare
Online
2015-09-21
DOI
10.1517/14656566.2015.1084502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type 1 Diabetes Treatment Beyond Insulin
- (2016) Lindsay B. Harrison et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes
- (2015) DIABETES CARE
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
- (2015) Caroline Bonner et al. NATURE MEDICINE
- Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: Simultaneous Glucose Lowering and Renal Protection?
- (2014) David Z.I. Cherney et al. Canadian Journal of Diabetes
- Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
- (2014) Andrea N. Traina et al. Canadian Journal of Diabetes
- The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
- (2014) David ZI Cherney et al. Cardiovascular Diabetology
- Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
- (2014) Robert R. Henry et al. DIABETES CARE
- Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial
- (2014) Bruce A. Perkins et al. DIABETES CARE
- Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes
- (2014) Elizabeth M Lamos et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport
- (2014) M. A. Abdul-Ghani et al. JOURNAL OF INTERNAL MEDICINE
- Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial
- (2014) Kurt J Griffin et al. Lancet Diabetes & Endocrinology
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- GLP-1 agonists in type 1 diabetes
- (2013) Jeremy Pettus et al. CLINICAL IMMUNOLOGY
- The Emerging Global Epidemic of Type 1 Diabetes
- (2013) Jaakko Tuomilehto Current Diabetes Reports
- Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
- (2013) Tara Ghazi et al. DIABETES CARE
- Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
- (2013) Gayatri Sarkar et al. DIABETES CARE
- Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study
- (2013) K.V.S. Hari Kumar et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Liraglutide as Additional Treatment to Insulin in Obese Patients with Type 1 Diabetes Mellitus
- (2013) Nitesh Kuhadiya et al. Endocrine Practice
- Metformin for the Treatment of Hyperandrogenism in Adolescents with Type 1 Diabetes Mellitus
- (2013) Ethel Codner et al. Hormone Research in Paediatrics
- Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
- (2013) Tafuri Kimberly Sue et al. Journal of Clinical Research in Pediatric Endocrinology
- Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study
- (2012) D. Pitocco et al. DIABETES OBESITY & METABOLISM
- Experiences of using blood glucose targets when following an intensive insulin regimen: a qualitative longitudinal investigation involving patients with Type 1 diabetes
- (2012) D. Rankin et al. DIABETIC MEDICINE
- A review of the efficacy and safety of oral antidiabetic drugs
- (2012) Stephanie Aleskow Stein et al. Expert Opinion On Drug Safety
- Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual -Cell Function
- (2011) U. Kielgast et al. DIABETES CARE
- Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
- (2011) S. L. Ellis et al. DIABETIC MEDICINE
- Liraglutide as additional treatment for type 1 diabetes
- (2011) Ajay Varanasi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
- (2010) V. S. Raman et al. DIABETES CARE
- Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial
- (2010) S. K. Garg et al. DIABETES OBESITY & METABOLISM
- The use of metformin in type 1 diabetes: a systematic review of efficacy
- (2010) S. Vella et al. DIABETOLOGIA
- Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients
- (2010) Urd Kielgast et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients
- (2010) Sayaka Kubo et al. Journal of Diabetes Investigation
- Effects of Exenatide Alone and in Combination With Daclizumab on -Cell Function in Long-Standing Type 1 Diabetes
- (2009) K. I. Rother et al. DIABETES CARE
- Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
- (2009) S. S. Lund et al. DIABETES OBESITY & METABOLISM
- Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
- (2008) W. L. Suarez-Pinzon et al. DIABETES
- Rosiglitazone preserves islet β-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study
- (2008) Zhifang Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Beta cell mass in diabetes: a realistic therapeutic target?
- (2008) J. J. Meier DIABETOLOGIA
- Effect of Vildagliptin on Glucagon Concentration During Meals in Patients with Type 1 Diabetes
- (2008) J. Foley et al. HORMONE AND METABOLIC RESEARCH
- The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial
- (2008) Monique L Stone et al. PEDIATRIC DIABETES
- Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study
- (2008) Søren Søgaard Lund et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started